• 出版社/出版日：Mordor Intelligence / 2019年12月26日
|Single User||￥446,250 (USD4,250)||▷ お問い合わせ|
|Multi User||￥498,750 (USD4,750)||▷ お問い合わせ|
|Global Site License||￥787,500 (USD7,500)||▷ お問い合わせ|
Microbial Identification Market – Growth, Trends, and Forecast (2019 – 2024)
Several technological advances using simple molecular methods have become available in recent years for microbial identification and show potential for cost-benefit, specifically, peptide nucleic acid fluorescent in situ hybridization (PNA-FISH) and targeted real-time PCR such as GeneXpert assays. PNA-FISH has been the most extensively studied technology in terms of the collaboration between pharmacy and medical intervention. Multiplex and broad-range molecular diagnostics are capable of lowering the result-time and increased sensitivity compared to growth-based blood culture systems.
There are thousands of pathogens known to cause disease in humans, and standard PCR assays have been developed to detect the most commonly occurring pathogens. Pyrosequencing and multitarget PCRs are two very useful strategies currently in development for clinical laboratories. Additionally, these new broad-based techniques have merit, based on their ability to identify organisms difficult to culture or newly emerging strains, as well as their capacity to track disease transmission.
Therefore, the market for microbial identification is expected to increase over the forecast period due to advancements in microbial identification which are enabling lower costs, lower result time and greater efficiency.
Scope of the Report
Microbial identification can be defined as “microbial characterization by a limited spectrum of tests pre-chosen and appropriate to the problem being studied.Following is the scope of the studied market report:
Key Market Trends
Instruments Lead the Product & Service Segment of Microbial Identification Market
There have been major advances in the identification techniques of clinically significant microorganisms. The spectrum of the identifiable organism has steadily increased over the years to become more inclusive of various microorganism strains. These include methods of faster identification of isolated organisms with mass spectrometry (MS) in clinical specimens and simpler.
The instruments available in the current market include AXIMA Microorganism Identification System, (manufactured by Shimadzu) and MicroSEQ Microbial Identification System (manufactured by Thermo Fischer Scientific), among others.
The above mentioned commercial instruments for microbial identification are based on techniques of mass spectrometry (MS), polymerase chain reaction (PCR) and time-of-flight mass spectrometry (TOF-MS). These advanced microbial identification systems are however not available uniformly across the globe, instead, their use is highly concentrated in North America and Europe region. Such factors give high opportunities for growth over the forecast period.
North America Holds the Largest Share in the Market
Being technologically advanced, North America has a good hold on the latest technologies that come into the market. Also, there is a good presence of big players in the North America region which indicates the availability of products related to microbial identification. However, there are some products of microbial identification which are yet to be approved in the United States which is acting as a barrier to the growth of the market over there.
The market studied is moderately competitive and there are global as well as local players that are actively present in the market. In terms of major players, few companies are currently playing good and hold a healthy share in the market. Eg. Thermofisher Scientific, BioMérieux SA, Beckman Coulter, Inc., Shimadzu Corporation, and Becton, Dickinson and Company are the major players in the market along with the local and smaller companies that hold substantial share.
Reasons to Purchase this report:
The market estimate (ME) sheet in Excel format
Report customization as per the client’s requirements
3 months of analyst support
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Incidence of Infectious Diseases
4.2.2 Technological Advancements in Microbial Identification
4.2.3 Increasing Food Safety Concerns
4.2.4 Government Initiatives and Funding for Promoting Microbial Identification
4.3 Market Restraints
4.3.1 High Cost of Automated Microbial Identification Systems
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Products & Services
5.2 By Method
5.2.1 Phenotypic Methods
5.2.2 Genotypic Methods
5.2.3 Proteomics-Based Methods
5.3 By Application
5.3.2 Food & Beverage Testing
5.3.4 Cosmetics and Personal Care Products Testing
5.3.5 Other Applications
5.4 By End-User
5.4.1 Hospitals, Clinics & Diagnostic Laboratories
5.4.2 Food & Beverage Manufacturers
5.4.3 Pharmaceutical Companies
5.4.4 Other End Users
5.5.1 North America
188.8.131.52 United States
184.108.40.206 United Kingdom
220.127.116.11 Rest of Europe
5.5.3 Asia Pacific
18.104.22.168 South Korea
22.214.171.124 Rest of Asia-Pacific
5.5.4 Middle East and Africa
126.96.36.199 South Africa
188.8.131.52 Rest of Middle East and Africa
5.5.5 South America
184.108.40.206 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Becton, Dickinson and Company
6.1.2 Biolog, Inc.
6.1.3 BioMerieux SA
6.1.4 Bruker Corporation
6.1.5 Charles River Laboratories International, Inc.
6.1.6 Danaher Corporation
6.1.7 Eurofins Scientific S.E.
6.1.8 Merck Millipore (Merck KGaA)
6.1.9 Shimadzu Corporation
6.1.10 Thermo Fisher Scientific Inc.
6.1.11 VWR Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS